CIPLA vs SUNPHARMA — stock comparison
Cipla Ltd (CIPLA), Sun Pharmaceutical Industries Ltd (SUNPHARMA): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, CIPLA grades highest (B+ 71). Not investment advice.
1-year price performance — higher line = stronger return
■ CIPLA -8.2%■ SUNPHARMA +7.8%Past year, rebased to 100
| CIPLA | SUNPHARMA | |
|---|---|---|
| Traddx grade | B+ (71) | B (69) |
| Price | ₹1,391.80 | ₹1,881.70 |
| Today | -0.09% | 0.04% |
| P/E | 36.20 | 36.70 |
| ROE | 11.60% | 16.00% |
| Net margin | 15.53% | 14.19% |
| Debt / equity | 0.02 | 0.04 |
| 52-week high | ₹1,539.25 | ₹2,047.55 |
| 52-week low | ₹1,165.55 | ₹1,583.60 |
Green = the strongest figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.
Open CIPLA live → Open SUNPHARMA live →